Cargando…
Hypogonadism and erectile dysfunction as harbingers of systemic disease
Prescription sales of Testosterone and erectile aids such as phosphodiesterase-5 inhibitors are at an all-time high, underscoring the importance of hypogonadism (HG) and erectile dysfunction (ED) to men’s health. The effect of these debilitating conditions has a major impact on the quality of men’s...
Autor principal: | Chiles, Kelly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837306/ https://www.ncbi.nlm.nih.gov/pubmed/27141446 http://dx.doi.org/10.21037/tau.2016.03.05 |
Ejemplares similares
-
The triad of erectile dysfunction, hypogonadism and the metabolic syndrome
por: Shabsigh, R, et al.
Publicado: (2008) -
Hypogonadism and erectile dysfunction
in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013) -
When is a varicocele repair indicated: the dilemma of hypogonadism and erectile dysfunction?
por: Dabaja, Ali A, et al.
Publicado: (2016) -
New treatment possibilities for postcovid hypogonadism and erectile dysfunction
por: Knigavko, Prof. Oleksandr V., et al.
Publicado: (2022) -
New treatment possibilities for postcovid hypogonadism and erectile dysfunction.
por: Knigavko, Oleksandr V., et al.
Publicado: (2022)